Cernostics Company
Cernostics is a life science company developing new molecular diagnostic tests to treat cancer.
Investors Number:
9
Technology:
Genetic Test & Molecular Diagnostics
Total Funding:
$65M
Founded Date:
01.01.2008
Headquarters:
Danville, Pennsylvania, United States
Estimated Revenue:
$1M to $10M
Last Funding Type:
Private Equity
Funding Status:
Early Stage Venture
Industry:
Deep Diagnostics